Risk factors for mortality in patients treated with ceftazidime-avibactam for ceftazidime-avibactam susceptible carbapenem-resistant Klebsiella pneumoniae bacteremia

類似資料

• Ceftazidime/avibactam as a possible treatment option for carbapenem-resistant Enterobacterales infections
  著者:: Ana Kaftandzieva, 等
  出版事項: (2025-12-01)
• Activity of aztreonam-avibactam and ceftazidime-avibactam against β-lactamase-producing enterobacterales Isolates from United States hospitals
  著者:: Lalitagauri M Deshpande, 等
  出版事項: (2025-09-01)
• Clinical Efficacy of Ceftazidime-Avibactam in the Treatment of Infections Caused by Carbapenem–Resistant Gram-Negative Bacteria
  著者:: S. V. Yakovlev
  出版事項: (2021-10-01)
• Mortality of metallo-β-lactamase-producing Enterobacterales bacteremias with combined ceftazidime–avibactam plus aztreonam vs. other active antibiotics: a multicenter target trial emulationResearch in context
  著者:: Ivan Alfredo Huespe, 等
  出版事項: (2025-09-01)
• Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria
  著者:: S. V. Nedogoda, 等
  出版事項: (2019-07-01)